CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 103 filers reported holding CONSTELLATION PHARMCETICLS I in Q4 2019. The put-call ratio across all filers is 0.31 and the average weighting 2.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $795,000 | -93.5% | 23,515 | -95.5% | 0.00% | -100.0% |
| Q1 2021 | $12,312,000 | -26.9% | 526,371 | -10.0% | 0.01% | -30.0% |
| Q4 2020 | $16,840,000 | +1249.4% | 584,743 | +849.7% | 0.01% | +900.0% |
| Q3 2020 | $1,248,000 | +167.8% | 61,569 | +296.9% | 0.00% | – |
| Q2 2020 | $466,000 | +120.9% | 15,514 | +130.7% | 0.00% | – |
| Q1 2020 | $211,000 | -19.2% | 6,725 | +20.5% | 0.00% | – |
| Q4 2019 | $261,000 | +832.1% | 5,582 | +23.6% | 0.00% | – |
| Q3 2019 | $28,000 | -49.1% | 4,517 | -0.9% | 0.00% | – |
| Q2 2019 | $55,000 | -79.6% | 4,559 | -77.3% | 0.00% | – |
| Q1 2019 | $270,000 | +1185.7% | 20,120 | +276.8% | 0.00% | – |
| Q4 2018 | $21,000 | -83.5% | 5,339 | -72.1% | 0.00% | – |
| Q3 2018 | $127,000 | – | 19,148 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $45,338,000 | 33.03% |
| Ponoi Management, LLC | 1,880,623 | $54,162,000 | 30.99% |
| VR Adviser, LLC | 4,016,873 | $115,686,000 | 17.01% |
| Column Group LLC | 2,626,631 | $75,647,000 | 6.86% |
| COMMODORE CAPITAL LP | 423,708 | $12,203,000 | 6.64% |
| GREAT POINT PARTNERS LLC | 1,024,800 | $29,514,000 | 4.79% |
| Venrock Management V, LLC | 1,557,276 | $44,850,000 | 4.23% |
| Ghost Tree Capital, LLC | 625,000 | $18,000,000 | 4.01% |
| Euclidean Capital LLC | 554,325 | $15,965,000 | 3.38% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 737,406 | $21,237,000 | 3.07% |